Open AccessProliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
Author(s) -
V. Diana,
Carmelina Gordon,
Iván J. Suñer,
Kimberly Reed,
Hadi Moini,
Andrea Gibson,
Weiming Du,
Chirag P. Shah
Publication year - 2022
Publication title -
journal of vitreoretinal diseases
Language(s) - English
Resource type - Journals
eISSN - 2474-1272
pISSN - 2474-1264
DOI - 10.1177/24741264221093914
Subject(s) - medicine , diabetic retinopathy , diabetic macular edema , post hoc analysis , macular edema , ophthalmology , aflibercept , retinopathy , diabetes mellitus , visual acuity , bevacizumab , endocrinology , chemotherapy
This work aimed to assess the incidence of proliferative diabetic retinopathy (PDR) events and improvement to mild non-PDR (NPDR) or better after intravitreal aflibercept injection (IAI) or laser treatment (control) in diabetic macular edema (DME).